As shown in Table 1, low ApoF expression was significantly associated with liver cirrhosis (P = 0.007), Barcelona Clinic Liver Cancer (BCLC) stage (P = 0.020) and tumor-node-metastasis (TNM) stage (P = 0.049). This evidence concerns the gene APOF and liver cancer.